Literature DB >> 28628270

Serum Klotho, vitamin D, and homocysteine in combination predict the outcomes of Chinese patients with multiple system atrophy.

Yue Guo1,2, Xiao-Dong Zhuang1, Wen-Biao Xian3, Ling-Ling Wu1, Ze-Na Huang1, Xun Hu1, Xiang-Song Zhang4, Ling Chen3, Xin-Xue Liao1,2.   

Abstract

AIMS: Neuroinflammation contributed to the pathogenesis of multiple system atrophy (MSA). We aimed to detect the correlation between inflammatory mediators, such as Klotho (Klt), vitamin D (25(OH)D) and homocysteine (Hcy), and disease severity among MSA patients.
METHODS: A total of 53 MSA patients, 65 PD patients, and 62 normal subjects were recruited in our cross-sectional study. Serum Klotho (Klt), vitamin D (25(OH)D), and homocysteine (Hcy) levels were measured. Several scales were undertaken to assess the motor/nonmotor function and cognitive impairment of MSA.
RESULTS: Decreased Serum Klt and 25(OH)D levels and increased Hcy levels were found in patients with MSA, compared with healthy controls. These results were more pronounced in male patients. The three biomarkers also displayed differences between MSA and PD subgroups based on genders. Interestingly, Klt, 25(OH)D and Hcy levels associated with cognition impairment, motor dysfunction, mood/cardiovascular disorder among MSA patients. In addition, the combination of Klt, 25(OH)D and Hcy had a better diagnostic ability for distinguishing MSA patients from healthy subjects, as well as distinguishing male MSA patients from male PD patients.
CONCLUSION: This study suggested that Klt, 25(OH)D and Hcy levels could be a potential predictor for MSA severity evaluation.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  Klotho; homocysteine; multiple system atrophy; neuroinflammation; vitamin D

Mesh:

Substances:

Year:  2017        PMID: 28628270      PMCID: PMC6492708          DOI: 10.1111/cns.12711

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  62 in total

Review 1.  Biomarkers in Parkinson's disease: an update.

Authors:  Alexander Shtilbans; Claire Henchcliffe
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

2.  The p38 MAP Kinase Family as Regulators of Proinflammatory Cytokine Production in Degenerative Diseases of the CNS.

Authors:  Adam D Bachstetter; Linda J Van Eldik
Journal:  Aging Dis       Date:  2010-09-24       Impact factor: 6.745

Review 3.  Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla; Myles Wolf
Journal:  Nat Rev Nephrol       Date:  2014-04-01       Impact factor: 28.314

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.

Authors:  Maria C Rodriguez-Oroz; Pablo Martínez Lage; Jose Sanchez-Mut; Isabel Lamet; Javier Pagonabarraga; Jon B Toledo; David García-Garcia; Pedro Clavero; Lluis Samaranch; Cecilia Irurzun; Juan M Matsubara; Jaione Irigoien; Emilia Bescos; Jaime Kulisevsky; Jordi Pérez-Tur; Jose A Obeso
Journal:  Mov Disord       Date:  2009-07-30       Impact factor: 10.338

6.  Serum 25-hydroxyvitamin D concentrations in Mid-adulthood and Parkinson's disease risk.

Authors:  Srishti Shrestha; Pamela L Lutsey; Alvaro Alonso; Xuemei Huang; Thomas H Mosley; Honglei Chen
Journal:  Mov Disord       Date:  2016-04-19       Impact factor: 10.338

7.  Rho kinase inhibitor fasudil protects against β-amyloid-induced hippocampal neurodegeneration in rats.

Authors:  Yun Song; Xu Chen; Li-Yan Wang; Wei Gao; Mei-Jia Zhu
Journal:  CNS Neurosci Ther       Date:  2013-05-03       Impact factor: 5.243

8.  Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).

Authors:  Jordan M Ramsey; Jason D Cooper; Mariska Bot; Paul C Guest; Femke Lamers; Cynthia S Weickert; Brenda W J H Penninx; Sabine Bahn
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.240

9.  Klotho and smoking--An interplay influencing the skeletal muscle function deficits that occur in COPD.

Authors:  M S Patel; A V Donaldson; A Lewis; S A Natanek; J Y Lee; Y M Andersson; G Haji; S G Jackson; B J Bolognese; J P Foley; P L Podolin; P L B Bruijnzeel; N Hart; N S Hopkinson; W D-C Man; P R Kemp; M I Polkey
Journal:  Respir Med       Date:  2016-02-15       Impact factor: 3.415

10.  Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum.

Authors:  Daniel Lindqvist; Eli Kaufman; Lena Brundin; Sara Hall; Yulia Surova; Oskar Hansson
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

View more
  6 in total

1.  Serum Klotho, vitamin D, and homocysteine in combination predict the outcomes of Chinese patients with multiple system atrophy.

Authors:  Yue Guo; Xiao-Dong Zhuang; Wen-Biao Xian; Ling-Ling Wu; Ze-Na Huang; Xun Hu; Xiang-Song Zhang; Ling Chen; Xin-Xue Liao
Journal:  CNS Neurosci Ther       Date:  2017-06-19       Impact factor: 5.243

Review 2.  Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis.

Authors:  Shengri Cong; Chunchen Xiang; Hailong Wang; Shuyan Cong
Journal:  J Neurol       Date:  2020-03-11       Impact factor: 4.849

3.  Acute Treatment with Nicotinamide Riboside Chloride Reduces Hippocampal Damage and Preserves the Cognitive Function of Mice with Ischemic Injury.

Authors:  Yin-Hong Cheng; Wei-Feng Zong; Jian-Hua Zhao; Xian-Jie Wei; Zhe Xu; Yuan Yuan; Yi-Fan Jiang; Xiang Luo; Wei Wang; Wen-Sheng Qu
Journal:  Neurochem Res       Date:  2022-05-19       Impact factor: 4.414

Review 4.  Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs.

Authors:  Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Iphigenia Kanara; Anastasios N Mavrakis; Julie Pernokas; Mark Pernokas; Carl A Pinkert; Whitney R Powers; Konstantina Sampani; Kosta Steliou; Demetrios G Vavvas; Robert J Zamboni; Krishna Kodukula; Xiaohong Chen
Journal:  Biores Open Access       Date:  2020-03-31

5.  Elevation of Plasma Homocysteine and Minor Hallucinations in Parkinson's Disease: A Cross-Sectional Study.

Authors:  Min Zhong; Sha Zhu; Ruxin Gu; Yaxi Wang; Yinyin Jiang; Yu Bai; Xu Jiang; Bo Shen; Jun Yan; Yang Pan; Jun Zhu; Li Zhang
Journal:  Behav Neurol       Date:  2022-03-07       Impact factor: 3.342

6.  Clinical and Imaging Features of Multiple System Atrophy: Challenges for an Early and Clinically Definitive Diagnosis.

Authors:  Hirohisa Watanabe; Yuichi Riku; Kazuhiro Hara; Kazuya Kawabata; Tomohiko Nakamura; Mizuki Ito; Masaaki Hirayama; Mari Yoshida; Masahisa Katsuno; Gen Sobue
Journal:  J Mov Disord       Date:  2018-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.